Screening Survivors of Childhood Acute Lymphoblastic Leukemia for Obesity, Metabolic Syndrome, and Insulin Resistance

REFERENCES

• Möricke A, Zimmermann M, Reiter A, Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24:265–284.
   PubMed Web of Science ®Google Scholar
• Aldhafiri F, Al-Nasser A, Al-Sugair A, Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia. Pediatr Blood Cancer. 2012;59:133–137.
   PubMed Web of Science ®Google Scholar
• Veringa SJ, van Dulmen-den Broeder E, Kaspers GJ, Veening MA. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;58:278–282.
   PubMed Web of Science ®Google Scholar
• Tonorezos ES, Vega GL, Sklar CA, Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer. 2012;58:31–36.
   PubMed Web of Science ®Google Scholar
• Mody R, Li S, Dover DC, Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Blood. 2008;111: 5515–5523.
   PubMed Web of Science ®Google Scholar
• Hatipoglu N, Ozturk A, Mazicioglu MM, Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr. 2008;167:383–389.
   PubMed Web of Science ®Google Scholar
• Neyzi O, Günöz H, Furman A, Türk çocuklarında vücut ağırlığı, boy uzunluğu, baş çevresi ve vücut kitle indeksi referans değerleri. [Reference ranges for body weight, height, head circumference and body mass index in Turkish children]. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008;51:1–14.
   Google Scholar
• Robert JK, Cynthia LO, Shumei SG, 2000 CDC Growth Charts for the United States: Methods and Development. DHHS Publication No. (PHS) 2002-1696, Series 11, No. 246. Hyattsville, Maryland. http://www.cdc.gov/nchs charts.
   Google Scholar
• Zimmet P, Alberti KG, Kaufman F, Consensus group the metabolic syndrome in children and adolescents—an IDF consensus report. Pediatr Diabetes. 2007;8:299–306.
   PubMed Web of Science ®Google Scholar
• Keskin M, Kurtoğlu S, Kendirci M, Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–e503.
   PubMed Web of Science ®Google Scholar
• Madeira IR, Carvalho CN, Gazolla FM, Cut-off point for homeostatic model assessment for insulin resistance (HOMA-IR) index established from receiver operating characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children. Arq Bras Endocrinol Metabol. 2008;52:1466–1473.
   PubMedGoogle Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl. 1):562–569. [Erratum in: Diabetes Care. 2010;33(4):e57].
   PubMedGoogle Scholar
• Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89: 2526–2539.
   PubMed Web of Science ®Google Scholar
• Bereket A, Turan S, Omar A, Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm Res. 2006;65:96–105.
   PubMedGoogle Scholar
• Cizmecioğlu FM, Etiler N, Hamzaoğlu O, Hatun S. Prevalence of metabolic syndrome in schoolchildren and adolescents in Turkey: a population based study. J Pediatr Endocrinol Metab. 2009;22: 703–714.
   PubMed Web of Science ®Google Scholar
• Zee P, Chen CH. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1986;8:294–299.
   PubMedGoogle Scholar
• Rogers PC, Meacham LR, Oeffinger KC, Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45:881–891 [review].
   PubMed Web of Science ®Google Scholar
• Asner S, Ammann RA, Ozsahin H, Obesity in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51:118–122.
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Mertens AC, Sklar CA, Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol. 2003;21:1359–1365.
   PubMed Web of Science ®Google Scholar
• Gofman I, Ducore J. Risk factors for the development of obesity in children surviving ALL and NHL. J Pediatr Hematol Oncol. 2009;31:101–107.
   PubMed Web of Science ®Google Scholar
• Trimis G, Moschovi M, Papassotiriou I, Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol. 2007;29:309–314.
   PubMed Web of Science ®Google Scholar
• Razzouk BI, Rose SR, Hongeng S, Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2007;25:1183–1189.
   PubMed Web of Science ®Google Scholar
• Kourti M, Tragiannidis A, Makedou A, Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol. 2005;27:499–501.
   PubMed Web of Science ®Google Scholar
• Kitiş Y, Bilgili N, Hisar F, Ayaz S. Frequency and affecting factors of metabolic syndrome in women older than 20 years of age. Anadolu Kardiyol Derg. 2010;10:111–119, doi:10.5152/akd.2010.033 [article in Turkish].
   PubMedGoogle Scholar
• Delibasi T, Karaaslan Y, Ustun İ, National prevalence of underweight, overweight and obesity in Turkey: cross sectional study of a representative adult population. Cent Eur J Med. 2007;2:294–303, doi:10.2478/S11536-007-0024-4.
   Google Scholar
• Karaman S, Ercan O, Yildiz I, Late effects of childhood ALL treatment on body mass index and serum leptin levels. J Pediatr Endocrinol Metab. 2010;23:669–674.
   PubMed Web of Science ®Google Scholar
• Moran A, Jacobs DR, Jr, Steinberger J, Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039–2044.
   PubMed Web of Science ®Google Scholar
• Gurney JG, Ness KK, Sibley SD, Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303–1312.
   PubMed Web of Science ®Google Scholar
• Franco C, Brandberg J, Lönn L, Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab. 2005;90:1466–1474.
   PubMed Web of Science ®Google Scholar
• Argüelles B, Barrios V, Pozo J, Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic Leukemia: a longitudinal study. J Clin Endocrinol Metab. 2000;85:4087–4092.
   PubMed Web of Science ®Google Scholar
• Birkebaek NH, Fisker S, Clausen N, Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998;30:351–356.
   PubMedGoogle Scholar
• Järvelä LS, Kemppainen J, Niinikoski H, Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;59:155–160.
   PubMed Web of Science ®Google Scholar